Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EC-MPS in Pediatric Renal Transplant
NCT00154206Phase 4Completed
- Sponsor
- Novartis
- Start
- Sep 2004
- Primary completion
- Jan 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of mycophenolate sodium in kidney transplant rejection, sponsored by Novartis. Started Sep 2004; status: completed.
02
Drugs
mycophenolate sodium
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT00154206.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00154206.